Related Experiment Videos
Acute demyelinating disease. Classification and non-invasive diagnosis
1Department of Neurology and Neuropathology, Göttingen University, Germany.
Acta Neurologica Scandinavica
|December 1, 1992
Summary
This study describes five young patients with acute demyelinating disease, including forms of multiple sclerosis (MS). Magnetic resonance spectroscopy (MRS) showed potential to non-invasively diagnose acute demyelination, possibly replacing biopsy.
Area of Science:
- Neurology
- Pediatric Neurology
- Neuroimaging
Background:
- Acute demyelinating diseases in children can present with varied clinical and imaging features.
- Distinguishing between different forms of acute demyelinating disease, such as Schilder's disease and Marburg's disease, is crucial for prognosis and management.
- Conventional diagnostic methods often involve invasive procedures like biopsy.
Observation:
- Five pediatric patients with biopsy-proven acute demyelinating disease were analyzed.
- Two cases were diagnosed as Schilder's disease, characterized by atypical MS presentation and large MRI lesions.
- Two cases presented as Marburg's disease (fulminant MS), and one as a second bout of classical MS.
Findings:
- Magnetic resonance imaging (MRI) revealed large bilateral lesions in Schilder's disease.
- Cerebrospinal fluid (CSF) findings varied across the different presentations.
- Localized proton magnetic resonance spectroscopy (MRS) in one case demonstrated a pattern typical of acute demyelination.
Implications:
- MRS offers a non-invasive method to directly examine focal cerebral abnormalities in acute demyelination.
- MRS findings suggest its potential to replace invasive biopsy in diagnosing acute demyelinating diseases in the future.
- This non-invasive approach could improve diagnostic efficiency and patient comfort in pediatric neurology.